Scientists first observed the biological phenomenon of restriction and modification in the 1950s, but they did not identify and isolate restriction enzymes until the late 1960s. 3 In 1970, Hamilton ...

The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.

Genetic medicines R&D is making strides with more complex DNA molecules. While these long sequences of synthetic DNA are key for developing gene and cell therapies as well as antibodies and other ...

Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life ...

Inside a bioreactor in the laboratory of the France-based startup Carbios, pulverized PET plastic waste—the kind of plastic found in drink bottles and polyester clothing—is mixed with water and ...

With over 75 years of enzyme technology expertise, look no further than Worthington, the primary enzyme producer. Our extensive technical-resource library is the definitive source for primary cell ...

Chemical reaction cascades have been generated in a cell using an artificial enzyme as a catalyst. Let there be light: An artificial metalloenzyme (blue) penetrates a mammalian cell, where it ...

Bruvi‘s B-pods take a novel approach that (probably correctly) assumes consumers are too lazy to return their aluminium pods to the manufacturer (looking at you, Nespresso), and too clumsy to do the ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...